Checkpoint Therapeutics
Professor of Medicine at Harvard Medical School, Professor of Cancer Immunology and Virology at the Dana-Farber Cancer Institute. Dr. Marasco’s research group focuses on the treatment of emerging infectious diseases and cancer. To greatly expand the use of human monoclonal antibodies in the treatment of cancer, Dr. Marasco founded the National Foundation of Cancer Research Center for Therapeutic Antibody Engineering. Dr. Marasco serves as Chairman of the Checkpoint Scientific Advisory Board.
This person is not in the org chart
This person is not in any offices
Checkpoint Therapeutics
Checkpoint Therapeutics is a clinical-stage, immuno-oncology biopharmaceutical company.